INTRODUCTION: A significant barrier to medical diagnostics in low-resource environments is the lack of medical care and equipment. Here we present a low-cost, cloud-connected digital microscope for applications at the point-of-care. We evaluate the performance of the device in the digital assessment of estrogen receptor-alpha (ER) expression in breast cancer samples. Studies suggest computer-assisted analysis of tumor samples digitized with whole slide-scanners may be comparable to manual scoring, here we study whether similar results can be obtained with the device presented. MATERIALS AND METHODS: A total of 170 samples of human breast carcinoma, immunostained for ER expression, were digitized with a high-end slide-scanner and the point-o...
INTRODUCTION: Breast carcinoma is the most common cancer among women in the urban Indian populatio...
INTRODUCTION: Manual interpretation of immunohistochemistry (IHC) is a subjective, time-consuming an...
Breast cancer risk factors and clinical outcomes vary by tumour marker expression. However, individu...
INTRODUCTION: A significant barrier to medical diagnostics in low-resource environments is the lack ...
Introduction: A significant barrier to medical diagnostics in low-resource environments is the lack ...
A significant barrier to medical diagnostics in low-resource environments is the lack of medical car...
<div><p>Introduction</p><p>A significant barrier to medical diagnostics in low-resource environments...
The benefit of quantifying estrogen receptor (ER) and progesterone receptor (PR) expression in breas...
Background: The Visiopharm automated estrogen receptor (ER) digital imaging analysis (DIA) algorithm...
Aims: Automation of downstream analysis may offer many potential benefits to routine histopathol...
Breast cancer risk factors and clinical outcomes vary by tumour marker expression. However, individu...
Abstract: The current treatment of breast cancer, the most frequent malignancy found in females, req...
Aims: To compare the assessment of steroid hormone receptor immunohistochemistry by eye and by compu...
Her-2/neu is overexpressed in 20-30% of breast cancer patients and is associated with a more aggress...
Introduction Accurate assessment of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 i...
INTRODUCTION: Breast carcinoma is the most common cancer among women in the urban Indian populatio...
INTRODUCTION: Manual interpretation of immunohistochemistry (IHC) is a subjective, time-consuming an...
Breast cancer risk factors and clinical outcomes vary by tumour marker expression. However, individu...
INTRODUCTION: A significant barrier to medical diagnostics in low-resource environments is the lack ...
Introduction: A significant barrier to medical diagnostics in low-resource environments is the lack ...
A significant barrier to medical diagnostics in low-resource environments is the lack of medical car...
<div><p>Introduction</p><p>A significant barrier to medical diagnostics in low-resource environments...
The benefit of quantifying estrogen receptor (ER) and progesterone receptor (PR) expression in breas...
Background: The Visiopharm automated estrogen receptor (ER) digital imaging analysis (DIA) algorithm...
Aims: Automation of downstream analysis may offer many potential benefits to routine histopathol...
Breast cancer risk factors and clinical outcomes vary by tumour marker expression. However, individu...
Abstract: The current treatment of breast cancer, the most frequent malignancy found in females, req...
Aims: To compare the assessment of steroid hormone receptor immunohistochemistry by eye and by compu...
Her-2/neu is overexpressed in 20-30% of breast cancer patients and is associated with a more aggress...
Introduction Accurate assessment of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 i...
INTRODUCTION: Breast carcinoma is the most common cancer among women in the urban Indian populatio...
INTRODUCTION: Manual interpretation of immunohistochemistry (IHC) is a subjective, time-consuming an...
Breast cancer risk factors and clinical outcomes vary by tumour marker expression. However, individu...